CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...